GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Isis Pharmaceuticals (ISIS) Chairman, CEO and President Stanley T Crooke sells 1,460 Shares

January 17, 2013 | About:
insider

insider

56 followers
Chairman, CEO and President of Isis Pharmaceuticals (ISIS) Stanley T Crooke sells 1,460 shares of ISIS on 01/16/2013 at an average price of $14 a share.

Isis Pharmaceuticals has a market cap of $1.43 billion; its shares were traded at around $14.24 with and P/S ratio of 12.5.

This is the annual revenues and earnings per share of ISIS over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ISIS.


CEO Recent Trades:



  • Chairman, CEO and President Stanley T Crooke sold 1,460 shares of ISIS stock on 01/16/2013 at the average price of 14. Stanley T Crooke owns at least 877,226 shares after this. The price of the stock has increased by 1.71% since.
  • Chairman, CEO and President Stanley T Crooke sold 89,462 shares of ISIS stock on 09/21/2012 at the average price of 14.63. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has decreased by 2.67% since.
  • Chairman, CEO and President Stanley T Crooke sold 27,074 shares of ISIS stock on 09/13/2012 at the average price of 14.55. Stanley T Crooke owns at least 873,391 shares after this. The price of the stock has decreased by 2.13% since.
  • Chairman, CEO and President Stanley T Crooke sold 75,000 shares of ISIS stock on 09/06/2012 at the average price of 14.62. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has decreased by 2.6% since.

This is the insider trade history vs. stock price of ISIS. For the complete insider trading history of ISIS, click here.




Directors and Officers Recent Trades:



  • SVP, Antisense Research C Frank Bennett sold 309 shares of ISIS stock on 01/16/2013 at the average price of 14. C Frank Bennett owns at least 2,110 shares after this. The price of the stock has increased by 1.71% since.
  • SVP, Development Richard S Geary sold 345 shares of ISIS stock on 01/16/2013 at the average price of 14. Richard S Geary owns at least 4,254 shares after this. The price of the stock has increased by 1.71% since.
  • SVP, Legal and General Counsel Patrick R. O'neil sold 1,296 shares of ISIS stock on 01/04/2013 at the average price of 10.76. Patrick R. O'neil owns at least 1,463 shares after this. The price of the stock has increased by 32.34% since.
  • Sr VP, Development Richard S Geary sold 265 shares of ISIS stock on 01/03/2013 at the average price of 10.84. Richard S Geary owns at least 3,823 shares after this. The price of the stock has increased by 31.37% since.
  • VP, Antisense Drug Discovery Brett P Monia sold 311 shares of ISIS stock on 01/03/2013 at the average price of 10.84. Brett P Monia owns at least 5,288 shares after this. The price of the stock has increased by 31.37% since.


For the complete insider trading history of ISIS, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 5.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide